Publications in collaboration with researchers from Instituto de Investigación Sanitaria Biocruces Bizkaia (15)

2024

  1. MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

    Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126

  2. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

    Actas Urologicas Espanolas

  3. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

    Clinica Chimica Acta, Vol. 542

  4. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  5. Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones

    Antibiotics, Vol. 12, Núm. 5

  6. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2022

  1. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

    Antibiotics, Vol. 11, Núm. 5

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  2. SARS-CoV-2-associated obliterative arteritis causing massive testicular infarction

    Clinics and Practice, Vol. 11, Núm. 2, pp. 246-249

  3. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2017

  1. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8

2012

  1. The impact of peptidase activity on clear cell renal cell carcinoma survival

    American Journal of Physiology - Renal Physiology, Vol. 303, Núm. 12